Security key
45258H106
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 2,765,928
- Total 13F value
- $5,781,309
- Share change
- +436,277
- SEC-reported price per share
- $2.09
- Number of holders
- 31
- Value change
- +$912,474
- Number of buys
- 18
- Number of sells
- 8
- Shares outstanding
- 69,928,708
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
31
Top holders
10
IMMX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Ownership snapshot
Top reported holders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bleichroeder LP
Disclosed value leader
Bleichroeder LP
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
Lead comparable stake: 1.2%
Showing 1-6 of 15 holder rows.
Quick read
Bleichroeder LP leads the comparable SEC ownership view at 1.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bleichroeder LP's linked filing trail.
Comparable ownership
Top 5
Bleichroeder LP
1.2%
VANGUARD GROUP INC
1%
GEODE CAPITAL MANAGEMENT, LLC
0.23%
MORGAN STANLEY
0.18%
NORTHERN TRUST CORP
0.13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bleichroeder LP |
13F
Company
|
1.2%
|
$1,759,500
850,000 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1%
|
$1,445,972
698,537 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.23%
|
$333,550
161,115 shares
|
— | 30 Jun 2025 |
| MORGAN STANLEY |
13F
Company
|
0.18%
|
$258,583
124,919 shares
|
— | 30 Jun 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
0.13%
|
$194,348
93,888 shares
|
— | 30 Jun 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.07%
|
$105,210
50,826 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
2,765,928
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
23
Q3 2025 holders
31
Holder diff
8
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend